| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Hydrocortisone | FAERS: 3 | US FAERS | |
| 2 | Dabigatran | FAERS: 2 | US FAERS | |
| 3 | LCZ 696 | FAERS: 1 | US FAERS | |
| 4 | Vemurafenib | FAERS: 1 | US FAERS | |
| 5 | Warfarin | FAERS: 1 | US FAERS | |
| 6 | apixaban | FAERS: 1 | US FAERS | |
| 7 | idelalisib | FAERS: 1 | US FAERS | |
| 8 | pazopanib | FAERS: 1 | US FAERS | |
| 9 | Octreotide | Canada Vigilance: 1 | Canada Vigilance | |
| 10 | trandolapril | Canada Vigilance: 1 | Canada Vigilance |
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120265
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.